Stockreport

BioMarin discontinues dosing in certain Voxzogo trials after safety concern [Yahoo! Finance]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF Syndrome, SHOX-deficiency and Aggrecan (ACAN)-deficiency after safety events in two investigator-led trials. According to a US Securities and Exchange Commission (SEC) [Read more]